Needham & Co Upgrades Natus Medical (BABY) to Buy
More News related to BABY
- natus Medical (BABY) Posts Q3 EPS of $0.13, Tops by 2c; Guides
- Natus Medical Announces 2009 Third Quarter Financial Results and Increases Fourth Quarter and Full Year 2009 Guidance
- Natus Medical to Hold 2009 Third Quarter Financial Results Conference Call on November 2
- Cowen & Co Upgrades Natus Medical (BABY) to Outperform
- Notable Mergers and Acquisitions of the Day 9/14: S/DT, CA, BABY
More News related to Upgrades
- Oppenheimer Issues Intraday Upgrade on Comcast (CMCSA)
- Canaccord Adams Upgrades Open Text (OTEX) to Buy; Raises Estimates & PT
- Stephens & Co Upgrades Aeropostale (ARO) to Overweight
- McAdams Wright Ragen Upgrades Zumiez (ZUMZ) to Buy
- Dahlman Rose Upgrades Intrepid Potash (IPI) to Hold
Needham & Co upgrades Natus Medical (Nasdaq: BABY) from Hold to Buy.
Natus Medical Incorporated (Natus) is a provider of healthcare products used for the screening, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and balance and mobility disorders.
Related Categories
UpgradesStocks Mentioned
-0.12Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
